44 completed, 9 recruiting, 8 unknown, 4 not yet recruiting. 17 Phase 2, 15 Phase 3, 14 Phase 4, 6 Not applicable, 6 Phase 1.
Follow Eunuchism: new trials by email Literature Review of Eunuchism trials Research Report on Eunuchism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anticipated Stigma, Illness Identity, and Quality of Life in Male Hypogonadism Hypogonadism, Male, Endocrine Disease | Not yet recruiting | Hacettepe University | 90 | 2026-10-01 | 2026-08-07 | |
| Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance Testosterone cypionate - Prostate Cancer, Hypogonadism, Male | Phase 4 | Not yet recruiting | University of Miami | 35 | 2026-08-31 | 2026-07-22 |
| AIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary Hypogonadism Fixed-Formula Microbiome-Targeted Oral Nutritional Supplement, Matched Oral Placebo - Hypogonadism, Male, Secondary Hypogonadism | Not applicable | Enrolling by invitation | Varol TUNALI | 112 | 2026-08-15 | 2026-09-29 |
| Anthropometric, Functional and Lifestyle Factors Associated With Testosterone Levels in Middle-Aged Men Observational Assessment - Testosterone Deficiency, Male Hypogonadism | Recruiting | Andijan State Medical Institute | 600 | 2026-06-01 | 2026-08-25 | |
| Clinical Evaluation of Subcutaneous Testosterone Implants in Men With Symptomatic Hypogonadism Subcutaneous Testosterone Implants - Male Hypogonadism, Testosterone Deficiency | Phase 2 | Not yet recruiting | University of Sao Paulo | 30 | 2026-03-01 | 2026-03-30 |
| Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men Testosterone Cypionate Injection 200 mg/mL - Hypogonadism, Male | Phase 4 | Not yet recruiting | Azurity Pharmaceuticals | 144 | 2026-02-01 | 2026-01-09 |
| EndoPAT Device for Endothelial Dysfunction in ED Daily low-dose PDE5 inhibitor therapy, Testosterone therapy as per clinical guidelines. - Erectile Dysfunction, Hypogonadism, Male | Not applicable | Recruiting | University of California, Irvine | 120 | 2025-08-13 | 2026-02-02 |
| TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation Testosterone Replacement Therapy - Hypogonadism, Male, End Stage Renal Disease (ESRD) | Phase 1 / Phase 2 | Active not recruiting | University of California, Los Angeles | 50 | 2025-07-01 | 2025-12-17 |
| Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes Stem cells - Gonadal Dysfunction, Gonadal Failure | Recruiting | Jumeirah American Clinic | 60 | 2025-04-08 | 2025-04-10 | |
| 52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism Testosterone enanthate - Hypogonadism, Male | Phase 3 | Recruiting | Halozyme Therapeutics | 100 | 2025-03-07 | 2026-02-18 |
| ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer Alectinib, Brigatinib, Lorlatinib 100 mg - NSCLC Stage IV, Sex Disorder | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 80 | 2024-08-05 | 2024-08-09 | |
| Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 Relugolix 120Mg Tab, Curcumin, Testosterone Undecanoate 237 MG Oral Capsule - Hypogonadism, Male | Phase 1 / Phase 2 | Unknown | University of Washington | 10 | 2024-06-01 | 2024-03-15 |
| The Effects of Natesto For Treatment Of Hypogonadism Natesto Nasal Product - Hypogonadism, Male, Infertility, Male | Early Phase 1 | Withdrawn | Baylor College of Medicine | 2024-03-01 | 2024-04-24 | |
| Relationship of the Microenvironment and Male Fertility Hormone replacement therapy - Male Infertility, Male Hypogonadism | Unknown | University of Illinois at Chicago | 150 | 2023-06-01 | 2023-04-20 | |
| Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men Testosterone, GnRH - Hypogonadism, Male, Testosterone Deficiency | Unknown | Royal College of Surgeons, Ireland | 60 | 2023-03-12 | 2023-03-17 | |
| Physical Exercise as a Sustainability Tool in Men With Dysmetabolic Hypogonadism Structured and personalized program of physical exercise - Hypogonadism, Male, Metabolic Syndrome | Not applicable | Unknown | Istituto Auxologico Italiano | 72 | 2023-01-11 | 2024-03-12 |
| Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors Lipid profile, Coronary artery assessment, Hormone levels for hypogonadism - Testicular Cancer, Survivorship | Recruiting | Indiana University | 150 | 2022-10-11 | 2026-07-27 | |
| Natesto Spermatogenesis Reboot NatestoTM - Hypogonadism, Male | Phase 4 | Completed | University of Florida | 13 | 2022-06-01 | 2025-06-13 |
| Testosterone Treatment in Men With Chronic Kidney Disease Jatenzo Pill - Hypogonadism, Male, Kidney Disease, Chronic | Phase 2 | Recruiting | St. Louis University | 20 | 2022-03-15 | 2026-04-30 |
| Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism Testosterone Undecanoate - Delayed Puberty, Male Hypogonadism | Unknown | Hospital de Niños R. Gutierrez de Buenos Aires | 27 | 2022-03-01 | 2024-02-28 |
Showing 20 of 73. Sign in to see all of them.
Hypogonadism (24) · Erectile Dysfunction (4) · Infertility, Male (4) · Endocrine System Diseases (3) · Gonadal Disorders (3) · Metabolic Syndrome (3) · Obesity (3) · Sarcopenia (3) · Azoospermia (2) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Motor Activity (2) · Muscular Atrophy (2) · Non-alcoholic Fatty Liver Disease (2)
Endocrine System Diseases (70) · Gonadal Disorders (70) · Hypogonadism (49) · Urogenital Diseases (16) · Male Urogenital Diseases (15) · Genital Diseases (14) · Genital Diseases, Male (13) · Pathological Conditions, Signs and Symptoms (13) · Signs and Symptoms (9) · Neoplasms (7) · Neoplasms by Site (6) · Nervous System Diseases (6) · Nutritional and Metabolic Diseases (6) · Glucose Metabolism Disorders (5) · Mental Disorders (5)
testosterone undecanoate (18) · Testosterone (11) · Testosterone Propionate (8) · testosterone 17 beta-cypionate (4) · testosterone enanthate (4) · Chorionic Gonadotropin (2) · Clomiphene (2) · Natesto (2) · Anastrozole (1) · Atorvastatin (1) · Carboplatin (1) · Coal Tar (1) · Curcumin (1) · Drug Evaluation (1) · Finasteride (1)
Clarus Therapeutics, Inc. (8) · Ferring Pharmaceuticals (4) · Lipocine Inc. (4) · University of Miami (3) · Endo USA Inc., a Keenova Therapeutics Company (2) · GlaxoSmithKline (2) · Marius Pharmaceuticals (2) · Seattle Institute for Biomedical and Clinical Research (2) · ANDROFERT - Clinica de Andrologia e Reproducao Humana (1) · Abbott (1) · Acerus Pharmaceuticals Corporation (1) · Albany Medical College (1) · Alexandra Kautzky-Willer (1) · Andijan State Medical Institute (1) · Azienda Ospedaliero-Universitaria di Modena (1)
United States (40) · Italy (5) · Canada (4) · Germany (4) · United Kingdom (4) · Denmark (3) · Brazil (2) · Turkey (Türkiye) (2) · United Arab Emirates (2) · Argentina (1) · Austria (1) · Croatia (1) · Egypt (1) · Ireland (1) · Kuwait (1)
Ronald Swerdloff, MD (4) · Anthony DelConte, MD (3) · Ranjith Ramasamy, MD (3) · Om Dhingra, PhD (2) · Abdukhalim Kh. Abdurakhimov, PhD (1) · Abraham Morgentaler, MD (1) · Ahmed M Eldokla, MD (1) · Alastair Smith, MB, ChB (1) · Aleksander Giwercman, MD (1) · Alexandra Kautzky-Willer, MD (1) · Alistair Smith, MB, ChB (1) · Anthony Delconte, MD (1) · Barbara Sahlin, MSc (1) · Bruce Kava, MD (1)
PMID 21474786, PMID 36272969, PMID 38606384, PMID 10664066, PMID 18567642, PMID 22783306, PMID 23533227, PMID 24012740, PMID 24326421, PMID 24344218, PMID 26695758, PMID 31492775, PMID 34191621, PMID 34763665, PMID 34994093, PMID 37126399, PMID 38591370, PMID 38764377, PMID 38852333, PMID 38909671, PMID 39252657, PMID 42705666
2017 (1), 2018 (1)